-
1
-
-
0017384270
-
High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
-
Gordon T, Castelli W P, Hjortland M C, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study [J]. Am J Med, 1977, 62:707-714.
-
(1977)
Am J Med
, vol.62
, pp. 707-714
-
-
Gordon, T.1
Castelli, W.P.2
Hjortland, M.C.3
-
2
-
-
0024501678
-
High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies
-
Gordon D J, Probstfield J L, Garrison R J, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies[J]. Circulation, 1989, 79: 8-15.
-
(1989)
Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
Probstfield, J.L.2
Garrison, R.J.3
-
3
-
-
0025978913
-
Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease
-
Romm P A, Green C E, Reagan K, et al. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease [J]. Am J Cardiol, 1991, 67: 479-483.
-
(1991)
Am J Cardiol
, vol.67
, pp. 479-483
-
-
Romm, P.A.1
Green, C.E.2
Reagan, K.3
-
4
-
-
34047106220
-
Effect of torcetrapib on the progression of coronary atherosclerosis
-
Nissen S E, Tardif J C, Nicholls S J, et al. Effect of torcetrapib on the progression of coronary atherosclerosis [J]. N Engl J Med, 2007, 356: 1304-1316.
-
(2007)
N Engl J Med
, vol.356
, pp. 1304-1316
-
-
Nissen, S.E.1
Tardif, J.C.2
Nicholls, S.J.3
-
5
-
-
77952357848
-
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
-
Rothblat G H, Phillips M C. High-density lipoprotein heterogeneity and function in reverse cholesterol transport [J]. Curr Opin Lipidol, 2010, 21:229-238.
-
(2010)
Curr Opin Lipidol
, vol.21
, pp. 229-238
-
-
Rothblat, G.H.1
Phillips, M.C.2
-
6
-
-
79952222810
-
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events
-
Rosenson R S, Brewer H B Jr, Chapman M J, et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events [J]. Clin Chem, 2011, 57: 392-410.
-
(2011)
Clin Chem
, vol.57
, pp. 392-410
-
-
Rosenson, R.S.1
Brewer Jr., H.B.2
Chapman, M.J.3
-
7
-
-
84870291668
-
High-density lipoprotein subclasses and their relationship to cardiovascular disease
-
Superko H R, Pendyala L, Williams P T, et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease[J]. J Clin Lipidol, 2012, 6: 496-523.
-
(2012)
J Clin Lipidol
, vol.6
, pp. 496-523
-
-
Superko, H.R.1
Pendyala, L.2
Williams, P.T.3
-
8
-
-
5444228543
-
High-density lipoprotein subfractions and risk of coronary artery disease
-
Morgan J, Carey C, Lincoff A, et al. High-density lipoprotein subfractions and risk of coronary artery disease [J]. Curr Atheroscler Rep, 2004, 6: 359-365.
-
(2004)
Curr Atheroscler Rep
, vol.6
, pp. 359-365
-
-
Morgan, J.1
Carey, C.2
Lincoff, A.3
-
9
-
-
77957661914
-
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
-
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25: 603-605.
-
(2010)
Eur J Epidemiol
, vol.25
, pp. 603-605
-
-
Stang, A.1
-
10
-
-
35248829949
-
Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome
-
Kuller L H, Grandits G, Cohen J D, et al. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome [J]. Atherosclerosis, 2007, 195: 122-128.
-
(2007)
Atherosclerosis
, vol.195
, pp. 122-128
-
-
Kuller, L.H.1
Grandits, G.2
Cohen, J.D.3
-
11
-
-
61849110301
-
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
-
Mora S, Otvos J D, Rifai N, et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women [J]. Circulation, 2009, 119: 931-939.
-
(2009)
Circulation
, vol.119
, pp. 931-939
-
-
Mora, S.1
Otvos, J.D.2
Rifai, N.3
-
12
-
-
58749094271
-
High-density lipoprotein particle size and concentration and coronary risk
-
El Harchaoui K, Arsenault B J, Franssen R, et al. High-density lipoprotein particle size and concentration and coronary risk [J]. Ann Intern Med, 2009, 150: 84-93.
-
(2009)
Ann Intern Med
, vol.150
, pp. 84-93
-
-
El Harchaoui, K.1
Arsenault, B.J.2
Franssen, R.3
-
13
-
-
70450186915
-
Lipoprotein particle subclasses, cardiovascular disease and HIV infection
-
Duprez D A, Kuller L H, Tracy R, et al. Lipoprotein particle subclasses, cardiovascular disease and HIV infection [J]. Atherosclerosis, 2009, 207: 524-529.
-
(2009)
Atherosclerosis
, vol.207
, pp. 524-529
-
-
Duprez, D.A.1
Kuller, L.H.2
Tracy, R.3
-
14
-
-
84864767131
-
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)
-
Mackey R H, Greenland P, Goff D C, et al. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis) [J]. J Am Coll Cardiol, 2012, 60: 508-516.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 508-516
-
-
Mackey, R.H.1
Greenland, P.2
Goff, D.C.3
-
15
-
-
84859373468
-
Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women
-
Berger J S, McGinn A P, Howard B V, et al. Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women[J]. Stroke, 2012, 43: 958-966.
-
(2012)
Stroke
, vol.43
, pp. 958-966
-
-
Berger, J.S.1
McGinn, A.P.2
Howard, B.V.3
-
16
-
-
0037099259
-
Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial
-
Rosenson R S, Otvos J D, Freedman D S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial[J]. Am J Cardiol, 2002, 90: 89-94.
-
(2002)
Am J Cardiol
, vol.90
, pp. 89-94
-
-
Rosenson, R.S.1
Otvos, J.D.2
Freedman, D.S.3
-
17
-
-
85027944383
-
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study
-
Parish S, Offer A, Clarke R, et al. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study[J]. Circulation, 2012, 125: 2469-2478.
-
(2012)
Circulation
, vol.125
, pp. 2469-2478
-
-
Parish, S.1
Offer, A.2
Clarke, R.3
-
18
-
-
0038201868
-
Effects of extended-release niacin on lipoprotein subclass distribution
-
Morgan J M, Capuzzi D M, Baksh R I, et al. Effects of extended-release niacin on lipoprotein subclass distribution [J]. Am J Cardiol, 2003, 91: 1432-1436.
-
(2003)
Am J Cardiol
, vol.91
, pp. 1432-1436
-
-
Morgan, J.M.1
Capuzzi, D.M.2
Baksh, R.I.3
-
19
-
-
0036794693
-
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
-
Asztalos B F, Horvath K V, McNamara J R, et al. Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients[J]. J Lipid Res, 2002, 43: 1701-1707.
-
(2002)
J Lipid Res
, vol.43
, pp. 1701-1707
-
-
Asztalos, B.F.1
Horvath, K.V.2
McNamara, J.R.3
-
20
-
-
0038300497
-
Change in alphal HDL concentration predicts progression in coronary artery stenosis
-
Asztalos B F, Batista M, Horvath K V, et al. Change in alphal HDL concentration predicts progression in coronary artery stenosis [J]. Arterioscler Thromb Vasc Biol, 2003, 23: 847-852.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 847-852
-
-
Asztalos, B.F.1
Batista, M.2
Horvath, K.V.3
|